TGFB1 and Hepatic fibrosis: Very recently, another HDAC inhibitor, suberoylanilide hydroxamic acid (SAHA or Vorinostat), was also able to suppress TGFβ-signaling and demonstrated antifibrotic effects in an animal model of CCl4-induced liver fibrosis [61].